Head-to-head · WeighScore
BloomWell Rx vs eMI Aesthetics
The verdict
eMI Aesthetics takes it — 70.1/100 to 61.3/100.
eMI Aesthetics grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. eMI Aesthetics is a US direct-to-consumer telehealth brand offering doctor-guided GLP-1 weight loss programs to eligible patients in all 50 states.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | BloomWell Rx | eMI Aesthetics |
|---|---|---|
| WeighScore | 61.3/100 | 70.1/100 |
| Grade | C | C |
| Scorecard rank | #298 | #113 |
| Semaglutide | $199/mo (starting dose, compounded) | $179/mo (all doses, compounded) |
| Tirzepatide | $249/mo (starting dose, compounded) | Not disclosed |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #298 · C
Strengths
- Transparent pricing — compounded semaglutide from $199/mo, tirzepatide (GLP-1/GIP) from $249/mo
- Free initial visit; fully online process with flexible dosing options
- Discloses meds are compounded by a licensed third-party pharmacy; also offers NAD+, sermorelin, glutathione
- Full legal suite published (Terms, Privacy, HIPAA Notice, Returns & Refunds)
Where it loses points
- 'Starts at' pricing — final cost depends on dose and plan
- Compounding pharmacy partner not named ('licensed third-party pharmacy')
- Not LegitScript-certified (no certification displayed)
- Operating medical entity not clearly named (site operated by a marketing agency)
Graded #113 · C
Strengths
- Available to eligible patients in all 50 states
- Offers both semaglutide and tirzepatide, plus an oral semaglutide option
- Intake and provider visits run through OpenLoop Health, an established telehealth network
Where it loses points
- Full per-drug pricing is not shown before intake; only an 'as low as 179/month' starting rate is published
- No fill pharmacy or named medical director is publicly listed
- Support appears limited to email, with no phone number or hours published
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.